MA54595A - Procédé de préparation d'agglomérats sphériques de timapiprant - Google Patents

Procédé de préparation d'agglomérats sphériques de timapiprant

Info

Publication number
MA54595A
MA54595A MA054595A MA54595A MA54595A MA 54595 A MA54595 A MA 54595A MA 054595 A MA054595 A MA 054595A MA 54595 A MA54595 A MA 54595A MA 54595 A MA54595 A MA 54595A
Authority
MA
Morocco
Prior art keywords
timapiprant
preparing spherical
spherical agglomerates
agglomerates
preparing
Prior art date
Application number
MA054595A
Other languages
English (en)
Inventor
Alain Burgos
Massimiliano Forcato
Eric Merifield
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of MA54595A publication Critical patent/MA54595A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA054595A 2018-12-27 2019-12-19 Procédé de préparation d'agglomérats sphériques de timapiprant MA54595A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18248081 2018-12-27

Publications (1)

Publication Number Publication Date
MA54595A true MA54595A (fr) 2022-04-06

Family

ID=65010443

Family Applications (2)

Application Number Title Priority Date Filing Date
MA054595A MA54595A (fr) 2018-12-27 2019-12-19 Procédé de préparation d'agglomérats sphériques de timapiprant
MA054596A MA54596A (fr) 2018-12-27 2019-12-19 Composition pharmaceutique comprenant des agglomérats sphériques de timapiprant

Family Applications After (1)

Application Number Title Priority Date Filing Date
MA054596A MA54596A (fr) 2018-12-27 2019-12-19 Composition pharmaceutique comprenant des agglomérats sphériques de timapiprant

Country Status (4)

Country Link
US (2) US20220184060A1 (fr)
EP (2) EP3902795A1 (fr)
MA (2) MA54595A (fr)
WO (2) WO2020136093A1 (fr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0324763D0 (en) 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
GB0504150D0 (en) 2005-03-01 2005-04-06 Oxagen Ltd Microcrystalline material
US20130052190A1 (en) * 2011-02-22 2013-02-28 Oxagen Limited CRTH2 Antagonists for Treatment of Eosinophilic Diseases and Conditions
GB201121557D0 (en) 2011-12-15 2012-01-25 Oxagen Ltd Process
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
US9668975B2 (en) * 2014-10-14 2017-06-06 PharmaDax Inc. Method of preparing drug agglomerate

Also Published As

Publication number Publication date
EP3902795A1 (fr) 2021-11-03
WO2020136095A1 (fr) 2020-07-02
MA54596A (fr) 2022-04-06
EP3902794A1 (fr) 2021-11-03
WO2020136093A1 (fr) 2020-07-02
US20220184059A1 (en) 2022-06-16
US20220184060A1 (en) 2022-06-16

Similar Documents

Publication Publication Date Title
MA51988A (fr) Procédé pour la préparation de composés utiles à traiter l'amyotrophie spinale
MA52665A (fr) Procédé d'amélioration de l'expression de l'hémoglobine foetale
DK3386511T3 (da) Fremgangsmåder til behandling af huntingtons sygdom
MA53920A (fr) Procédé de fourniture d'administration sous-cutanée d'anticorps anti-cd38
MA45155A (fr) Procédés de préparation d'oligomères morpholino de phosphorodiamidate
MA50169A (fr) Procédé de production d'un électrocatalyseur
MA43099A (fr) Procédé pour la préparation de chlorure de vinyle
MA44651A (fr) Procédé de préparation d'échantillons pour analyse et procédé d'analyse
MA45183A (fr) Procédés de préparation d'oligomères morpholino de phosphorodiamidate
MA49775A (fr) Procédés de préparation d'oligomères morpholino de phosphorodiamidate
PL3323581T3 (pl) Urządzenie wtryskowe do formowania łączącego elementu osłony złącza o stałej prędkości, sposób wtrysku łączącego elementu osłony złącza o stałej prędkości i osłona złącza o stałej prędkości wytwarzana sposobem wtryskowym w elemencie łączącym
MA55917A (fr) Procédé de cristallisation de dérivés d'aripiprazole dans des formulations à libération prolongée pour le traitement de la schizophrénie
MA53370A (fr) Procédé et intermédiaires pour la préparation de bilastine
MA54396A (fr) Procédé de préparation de n-phénylpyrazole-1-carboxamides
MA42423A (fr) Procédé de préparation d'un revêtement
MA50647A (fr) Procédé de régulation d'un puits
MA45768A (fr) Procédé pour la préparation de compositions d'immunoglobulines
MA49700A (fr) Procédé amélioré pour la préparation de dérivés d'aminopyrimidine
MA46100A (fr) Composition pharmaceutique comprenant de la rosuvastatine et de l'ézétimibe et son procédé de préparation
MA51432A (fr) Procédé de préparation d'une amino-pyrimidine et de ses intermédiaires
FR3048968B1 (fr) Procede de preparation d'alkylamines
EP3310377A4 (fr) Méthode de traitement de la maladie de crohn
MA50548A (fr) Dispositifs et procédé de préparation et de réalisation de tatouages cornéens
FR3052767B1 (fr) Procede de production de cristal d'apatite et cristal d'apatite
EP3429569A4 (fr) Méthodes destinées à prévenir ou à traiter la maladie de parkinson par farnésylation de paris